Is Sermorelin Legal in Wisconsin?
HealthRX.com
No Wisconsin rule names sermorelin, and US supply is compounded
See the public record for Sermorelin
At a glance
- FDA-approved sermorelin today / None; both Geref applications were withdrawn in 2009 [1]
- Geref's approved uses / Growth hormone deficiency in children, and a pituitary growth hormone test [1]
- Why it was withdrawn / The maker discontinued it in 2008 and asked FDA to withdraw; in 2013 FDA found it was not pulled for safety or effectiveness [1]
- What is sold now / Compounded sermorelin, which FDA does not review for safety, effectiveness or quality [2]
- FDA safety-risk bulk list / Sermorelin is not on it [3]
- Sport / Named on WADA's Prohibited List, prohibited at all times [10][11]
What sermorelin's FDA record shows
Sermorelin is a 29-amino-acid analogue of human growth hormone-releasing hormone; it prompts the pituitary to release the body's own growth hormone and is not growth hormone itself [4].
Two Geref applications were approved: NDA 019863, a 0.05 mg ampule for testing the pituitary's ability to secrete growth hormone (December 28, 1990), and NDA 020443, 0.5 mg and 1 mg vials for treating idiopathic growth hormone deficiency in children with growth failure (September 26, 1997). Neither covered adults, anti-aging, weight loss or athletic performance [1].
The manufacturer discontinued Geref in 2008 and asked FDA to withdraw the applications; FDA withdrew both approvals effective June 18, 2009 [1]. In March 2013 FDA determined Geref had not been withdrawn from sale for reasons of safety or effectiveness, and Drugs@FDA lists both products as discontinued. These are the only sermorelin applications in Drugs@FDA [1][5].
What is sold today
With Geref gone, sermorelin products in the US are compounded, and compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before they reach patients [2].
Where sermorelin sits on FDA's compounding lists
- It is absent from FDA's list of bulk substances that may present significant safety risks when compounded (content dated April 22, 2026) [3].
- On FDA's list of nominated bulk substances for outsourcing facilities, sermorelin acetate is in category 1, under evaluation (list updated March 21, 2025) [7].
- It appears in no category on FDA's list for state-licensed pharmacies and physicians (updated May 14, 2026) and is not among the six peptides in HHS's October 2026 draft enforcement-discretion policy [8][9].
Wisconsin
We found no Wisconsin statute or board rule that names sermorelin. The federal records show that no sermorelin product is FDA-approved today and that products sold in the US are compounded and not reviewed by FDA before marketing [1][2].
Questions worth asking
Sport
WADA's 2026 Prohibited List names sermorelin in S2.2.4, growth hormone releasing factors (GHRH and its analogues); it is prohibited at all times, in and out of competition, and the 2027 List names it as well [10][11].
Frequently asked questions
Is sermorelin legal in Wisconsin?
Is sermorelin FDA-approved?
Does WADA prohibit sermorelin?
References
Show all 11 referencesHide references
- Federal Register :: Request Access.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
- U.S. Food and Drug Administration.
- Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Official web page.
- World Anti-Doping Agency.
- World Anti-Doping Agency.